Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Biotage
Biotage
Activities:
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency
Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process
Regulatory
Biotage achieves Gold sustainability rating
EcoVadis,audited the company’s performance in several key areas, including environment, labour & human rights, ethics and sustainable procuremen
Finance
Biotage triples production capacity for vaccine-critical equipment
The availability of raw materials for vaccine production has been a major bottleneck
Analysis
Swedish Biotage taps into US market with PhyNexus acquisition
The California-based company specialises in lab-scale purification of biomolecules
Analysis
Biotage launches ACI (Accelerated Chromatographic Isolation)
Faster and more economical way to isolate pure compounds
Research & Development
Biotage launches integrated mass directed flash system
Reduces the number of steps required to purify and confirm a target compound
Manufacturing
Biotage unveils fully automated microwave peptide synthesiser
Robotic liquid handler and precise digital syringe pumps reduce reagent and solvent consumption
Subscribe now